Kodiak Sciences Inc. KOD
32.35
(0.87)
(2.62%)
as of 25 Sep
- Market cap
- $2.1B
- P/E
- 0.0×
Follow KOD
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(207.92%) | (149.49%) | (208.80%) | (368.37%) | |
| (73.58%) | (66.94%) | (76.39%) | (94.25%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(177.85%) | (90.35%) | (111.33%) | (154.24%) | |
Free Cash Flow per Share |
(2.41) | (2.57) | (2.39) | (2.55) | |
Free Cash Flow |
(127.29) | (136.51) | (148.12) | (159.90) | |
Capital Expenditures |
(0.59) | (0.51) | (1.18) | (1.40) | |
| Other line items | |||||
Cash ROIC |
(132.35%) | (37.03%) | (52.17%) | (84.76%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.58 | 0.59 | 0.64 | 0.66 | |
Depreciation/Fixed assets |
0.30 | 0.31 | 0.32 | 0.33 | |
Capex/Depreciation |
(0.02) | (0.02) | (0.05) | (0.05) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.40) | (2.56) | (2.38) | (2.53) | |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.02) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates